GD2-specific CAR and IL-15 expressing autologous NKT cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GD2-specific CAR and IL-15 expressing autologous NKT cells, covering 2025-09-19 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma [Phase 1]